KPRX · Kiora Pharmaceuticals Inc · Documents
Market Cap
$11.72M
Shares
4.42M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-09-08 | — | |
| 8-K | 2026-08-19 | — | |
| 8-K | 2026-08-07 | — | |
| 10-Q | 2026-08-07 | 2026-06-30 | |
| 8-K | 2026-06-18 | — | |
| 8-K | 2026-06-11 | 2026-06-10 | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| 8-K | 2026-05-08 | — | |
| DEF 14A | 2026-04-30 | 2026-04-16 | |
| 8-K | 2026-04-07 | 2026-04-03 | |
| 8-K | 2026-04-02 | 2026-04-01 | |
| 10-K | 2026-03-25 | 2025-12-31 | |
| 8-K | 2026-03-25 | — | |
| 10-Q | 2025-11-07 | 2025-09-30 | |
| 8-K | 2025-11-07 | — | |
| 8-K | 2025-08-13 | — | |
| 10-Q | 2025-08-08 | 2025-06-30 | |
| 8-K | 2025-08-08 | — | |
| 8-K | 2025-06-04 | — | |
| 8-K | 2025-06-03 | 2025-05-30 | |
| 10-Q | 2025-05-09 | 2025-03-31 | |
| 8-K | 2025-05-09 | — | |
| DEF 14A | 2025-04-30 | 2025-04-16 | |
| 8-K | 2025-03-25 | — | |
| 10-K | 2025-03-25 | 2024-12-31 | |
| 8-K | 2025-01-15 | 2025-01-10 | |
| 8-K | 2024-11-08 | — | |
| 10-Q | 2024-11-08 | 2024-09-30 | |
| 8-K | 2024-10-29 | — | |
| 8-K | 2024-08-09 | — | |
| 10-Q | 2024-08-09 | 2024-06-30 | |
| 8-K | 2024-07-30 | — | |
| 8-K | 2024-07-01 | 2024-06-28 | |
| 8-K | 2024-06-07 | 2024-06-06 | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| 8-K | 2024-05-10 | — | |
| 8-K | 2024-05-03 | 2024-05-01 | |
| 10-K | 2024-03-25 | 2023-12-31 | |
| 8-K | 2024-03-25 | — | |
| DEF 14A | 2024-03-25 | 2024-05-01 | |
| 8-K | 2024-02-12 | — | |
| 8-K | 2024-02-01 | 2024-01-31 | |
| 8-K | 2024-01-31 | 2024-01-25 | |
| 8-K | 2024-01-16 | — | |
| 8-K | 2023-11-09 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-09 | — | |
| 8-K | 2023-11-06 | 2023-11-04 | |
| 8-K | 2023-09-28 | 2023-09-27 | |
| 8-K | 2023-09-21 | 2023-09-20 |
Showing 1–50 of 127 filings